Medical Director, Global Medical Affairs - Lung Cancer

The Medical Director will provide scientific and clinical leadership across global medical affairs activities within lung cancer, setting the medical strategy including evidence generation, data analysis and interpretation, publications, scientific communications, medical training, medical information, and support for payer/market access evidence generation and publications. The Medical Director will work in a multifunctional, matrix organization with other medical affairs functions (global medical capabilities, oncology project management, MSL teams), as well as with commercial, clinical development, access and reimbursement, patient advocacy, and Oncology Business Units and regional/local medical leads.

This role will be accountable for development and execution of the medical strategy and tactics, as well as excellence in standards and practices, including advancing external collaborations with healthcare practitioners (including oncologists, , pathologists, and surgeons), research groups, payers and patient advocacy groups, and ensuring strong collaboration at global, regional and local levels across Takeda’s organization.

• Provide scientific/clinical expertise and leadership to develop and execute the lung cancer medical strategy and associated medical deliverables, including evidence generation, analysis and interpretation; scientific communications and publications, medical excellence and training, medical information, congress strategy and thought-leader engagement
• Develop an in-depth understanding of the needs of patients with lung cancer and demonstrate a focus on activities to meet those needs
• Represent Medical Affairs on the Global Product Team (GPT) and Global Brand Team (GBT) to provide medical input and insights from practicing clinicians into clinical development to enable more customer- and patient-centric clinical and brand planning
• Facilitate cross-regional alignment on medical strategy and deliverables and gather feedback from Local Operating Companies (LOCs) for input to development and life-cycle management plans
• Provide input into asset strategy for clinical development program, brand team strategy and tactical plan to support business success
• Lead or support evidence generation strategy and execution of Phase 3B/4 studies, including interventional and observational research, with a focus on lung cancer clinical pathways and relevant biomarker/diagnostic considerations
• Lead or support Collaborative and/or Investigator Initiated Studies (IISR) program
• Lead and execute global advisory board meetings and ensure communication of key findings and insights across the organization, to global clinical development, medical affairs and commercial teams
• Support global publication strategy development and execution of publication plan
• Provide strategic and scientific guidance into internal training plan, congress plan and company-sponsored symposia
• Foster relationships with key global cancer research organizations and institutions
• Establish, maintain, and direct interactions with key opinion leaders and HCPs .
• Lead or support development and execution of the global KOL engagement plan
• Build long-term cross-functional relationships with global functions, brand teams, clinical development, regional functions and Local Operating Countries (LOCs)
• Represent Takeda Oncology at external engagements (congresses, scientific meetings, etc.)

• MD, PharmD or PhD required
• 7+ years post-doctorate healthcare or related experience
• 5+ years Medical Affairs experience or related industry experience with launch experience preferred
• Deep knowledge of pharmaceutical industry dynamics and trends, including a good understanding of the…